Eastman Chemical

EMN · NYSE · Materials · United States

Financials at a glance

Source: SEC XBRL

Annual

FY2023FY2024FY2025$9.2B$9.2B$9.4B$9.4B$8.8B$8.8B5.4% margin5.4% marginRevenueNet margin

Quarterly · last 8

Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26Q2 '26$2.3B$2.3B$2.4B$2.4B$2.5B$2.5B$2.3B$2.3B$2.3B$2.3B$2.2B$2.2B$2.2B$2.2B$2.5B$2.5B7.3% margin7.3% marginRevenueNet margin

Revenue (FY2025)

$8.8B

Net margin

5.4%

ROE

8.0%

Revenue CAGR (2y)

-2.5%

Profit CAGR (2y)

-27.2%

EPS (FY2025)

4.10

Net profit (FY2025)

$474.0M

Ask MarketChacha about EMN

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

PeriodRevenueNet profitEPSNet marginROE
FY2025$8.8B$474.0M4.105.4%8.0%
FY2024$9.4B$905.0M7.679.6%15.7%
FY2023$9.2B$894.0M7.499.7%16.4%

Quarterly

PeriodRevenueNet profitEPSNet margin
2026Q2$2.5B$183.0M1.597.3%
2026Q1$2.2B$107.0M0.934.9%
2025Q3$2.2B$47.0M0.402.1%
2025Q2$2.3B$140.0M1.206.1%
2025Q1$2.3B$182.0M1.577.9%
2024Q3$2.5B$180.0M1.537.3%
2024Q2$2.4B$230.0M1.949.7%
2024Q1$2.3B$165.0M1.397.1%
2023Q3$2.3B$178.0M1.497.9%
2023Q2$2.3B$272.0M2.2711.7%
2023Q1$2.4B$134.0M1.125.6%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.